Institutional Ownership
Silexion Therapeutics Corp
CUSIP G1281K114*W EXP 08/15/202Q1 2026
13D / 13G Filings
0
Schedule 13D/13G on record
Beneficial Filers
0
Distinct reporting persons
Largest Stake
—
Max % of class reported
Institutional Holders
19
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
Schedule 13D (activist) & 13G (passive) 5%+ ownership filings
No 13D/13G filings on record yet
Schedule 13D/13G beneficial-ownership filings from 2020–present are ingested from SEC EDGAR. Coverage expands as the backfill and daily crawler run.
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Polar Asset Management Partners Inc. | 743.5K | $15.9K |
| 2 | Oasis Management Co Ltd. | 11.1K | $14.2K |
| 3 | Linden Advisors LP | 337.5K | $7.2K |
| 4 | Aristeia Capital, L.L.C. | 236.5K | $5.0K |
| 5 | Clear Street Group Inc. | 218.8K | $4.4K |
| 6 | Goldman Sachs Group Inc | 123.5K | $2.5K |
| 7 | Security Benefit Life Insurance Co /Ks/ | 150.0K | $1.9K |
| 8 | Jane Street Group, LLC | 74.9K | $1.5K |
| 9 | Picton Mahoney Asset Management | 57.2K | $1.2K |
| 10 | Context Capital Management, LLC | 51.2K | $1.0K |